We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Adding Follow-On Biologics to PDUFA Legislation 'Unlikely,' BIO CEO Says
Adding Follow-On Biologics to PDUFA Legislation 'Unlikely,' BIO CEO Says
September 7, 2007
It is “very unlikely” legislation creating an approval pathway for follow-on biologics will be included in the FDA Revitalization Act (FDARA), Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood said.